Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats

Stem Cells and Development

Volumn 20, Issue 2, 2011, Pages 223-232

  Paz, Ana H ^a   Salton, Gabrielle Dias ^a   Ayala Lugo, Ana ^a   Gomes, Cristiano ^a   Terraciano, Paula ^a   Scalco, Rosana ^b   Laurino, Claudia Cilene Fernandes Correia ^a   Passos, Eduardo Pandolfi ^a   Schneider, Marlon R ^c   Meurer, Luise ^a,b   Cirne Lima, Elizabeth ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETACELLULIN; INSULIN; NICOTINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE OVEREXPRESSION; GENETIC MARKER; GENETIC TRANSFECTION; GLUCOSE METABOLISM; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESODERM; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CELL DIFFERENTIATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GREEN FLUORESCENT PROTEINS; HUMANS; HYPERGLYCEMIA; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; STREPTOZOCIN;

RATTUS; RODENTIA;

EID: 78951480382     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0490     Document Type: Article

References (48)

1. Chen S, J Ding, C Yu, B Yang, DR Wood and PA Grayburn. (2007). Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Ther 14:1102-1110.
2. Shapiro AM, JR Lakey, EA Ryan, GS Korbutt, E Toth, GL Warnock, NM Kneteman and RV Rajotte. (2000). Islet transplantation in seven patients with type 1 diabetes mel-litus using a glucocorticoid-free immunosuppressive regi-men. N Engl J Med 343:230-238.
3. Fujiwaka T, SH Oh, LE Pi, HM Hatch, T Shuope and BE Petersen. (2005). Teratoma formation leads to failure of treatment for type 1 diabetes using embryonic stem cell-derived insulin producing cells. Am J Pathol166:1781-1791.
4. Kojima H, T Nakamura, Y Fujita, A Kishi, M Fujimiya, S Yamada, M Kudo, Y Nishio, H Maegawa, M Haneda, H Yasuda, I Kojima, M Seno, NC Wong, R Kikkawa and A Kashiwagi. (2002). Combined expression of pancre-atic duodenal homeobox 1 and islet factor 1 induces im-mature enterocytes to produce insulin. Diabetes 51:1398-1408.
5. Li WC, ME Horb, D Tosh and JM Slack. (2005). In vitro transdifferentiation of hepatoma cells into functional pan-creatic cells. Mech Dev 122:835-847.
6. Yang L, S Li, H Hatch, K Ahrens, JG Cornelius, PE Petersen and AB Peck. (2002). In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 99:8078-8083.
7. Ferber S, A Halkin, H Cohen, I Ber, Y Einay, I Goldberg, I Barshack, R Seiffers, J Kopolovic, N Kaiser and A Karasik. (2000). Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 6:568-572.
8. Bonner-Weir S, M Taneja, GC Weir, K Tatarkiewicz, KH Song, A Sharna and JJ O'Neil. (2000). In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999-8004.
9. Ramiya VK, M Maraist, KE Arfors, DA Schatz, AB Peck and JG Cornelius. (2000). Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 6:278-282.
10. Parnaud G, D Bosco, T Berney, F Pattou, J Kerr-Conte, MY Donath, C Bruun, T Mandrup-Poulsen, N Billestrup and PA Halban. (2008). Proliferation of sorted human and rat beta cells. Diabetologia 51:91-100.
11. Krampera M, A Pasini, G Pizzolo, L Cosmi, S Romagnani and F Annunziato. (2006). Regenerative and immunomod-ulatory potential of mesenchymal stem cells. Curr Opin Pharmacol 6:435-441.
12. Meirelles LS and NB Nardi. (2003). Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion and characterization. Br J Haematol 123:702-711.
13. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
14. Li L, L Furong, H Qi, G Feng, K Yuan, H Deng and H Zhou. (2008). Coexpression of Pdx1 and betacellulin in mesenchy-mal stem cells could promote the differentiation of nestin-positive ephitelim-like progenitors and pancreatic islet-like spheroids. Stem Cells Dev 17:815-823.
15. Karnieli O, Y Izhar-Prato, S Bulvik and S Efrat. (2007). Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25:2837-2844.
16. Davani B, L Ikonomou, BM Raaka, E Geras-Raaka, RA Morton, B Marcus-Samuels and MC Gershengon. (2007). Human islet-derived precursor cells are mesenchymal stro-mal cells that differentiate and mature hormone-expressing cells in vivo. Stem Cells 25:3215-3222.
17. Schneider MR and E Wolf. (2009). The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218: 460-466.
18. Miettinen M, P Ormio, E Hakonen, M Banerjee and T Otonkski. (2008). EGF receptor in pancreatic ß-cell mass regulation. Biochem Soc Trans 36:280-285.
19. Sahin U, G Weskamp, K Kelly, HM Zhou, S Higashiyama, J Peschon, D Hartmann, P Saftig and CP Blobel. (2004). Dis-tinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769-779.
20. Shing Y, G Christofori, D Hanahan, Y Ono, R Sasada, K Igarashi and J Folkman. (1993). Betacellulin: a mitogen from pancreatic beta cell tumors. Science 259:1604-1607.
21. Detemerco C, GM Beattie, SA Dib, AD Lopez and A Hayek. (2000). A role for activin and betacellulin in human fetal pancreatic cell differentiation and grothw. J Clin Endocrinol Metab 85:3892-3897.
22. Li L, M Seno, H Yamada and I Kojima. (2003). Betacellulin improves glucose metabolism by promoting conversion of intraislet precursor p-cells in streptozotocin-treated mice. Am J Physiol Endocrinol Metab 285:E577-E583.
23. Mashima H, H Ohnishi, K Wakabayashi, T Mine, J Miyga-wa, T Hanafusa, M Seno, H Yamada and I Kojima. (1996). Betacellulin and activin A coordinately convert amylase-se-creting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest 97:1647-1654.
24. Cho YM, JM Lim, DH Yoo, JH Kim, SS Cheng, Park SG, TH Kim, SK Oh, YM Choi, SY Moon, KS Park and HK Lee. (2008). Betacellulin and nicotinamode sustain PDX1 expression and induce pancreatic p-cell differentiation in human embryonic stem cells. Biochem Biophys Res Commun 366:129-134.
25. Li L, Z Yi, M Seno and I Kojima. (2004). Activin A and Betacellulin: effect on regeneration of pancreatic beta-cells in neonatal steptozotocin- treated rats. Diabetes 53:608-615.
26. Schneider MR, M Dahlhoff, N Herbah, I Renner-Mueller, C Dalke, O Puk, J Graw, R Wanke and E Wolf. (2005). Beta-cellulin overexpression in transgenic mice causes dispro-portionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. Endocrinology 146:5237-5246.
27. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Corthenbach, FC Marini, RJ Deans, DS Krause and A Keat-ing. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position state-ment. Cytotherapy 7:393-395.
28. Lumelsky N, O Blondel, P Laeng, I Velasco, R Ravin and R Mckay. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Sci-ence 292:1389-1394.
29. Chandra V, G Swetha, S Phadnis, PD Nair and RR Bhonde. (2009). Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 27:1941-1953.
30. Gao F, DQ Wu, YH Hu, GX Jin, GD Li, TW Sun and FJ Li. (2008). In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res 151:293-302.
31. Choi KS, JS Shin, JJ Lee, SB Kim and CW Kim. (2005). In vitro trans-differentiation of rat Mesenchymal stem cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 330:1299-1305.
32. Trucco M. (2005). Regeneration of pancreatic p cell. J Clin Invest 115:5-12.
33. Huotari MA, J Palgi and T Otonkoski. (1998). Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology 139:1494-1499.
34. Dahlhoff M, PM Dames, A Leechner, N Herbach, L van Burck, R Wanke, E Wolf and MR Schneider. (2009). Beta-cellulin overexpression in transgenic mice improves glucose tolerance and enhances insulin secretion by isolated islets in vitro. Mol Cell Endocrinol 299:188-193.
35. Yanomoto Y, S Yamada, T Kodera, A Hara, K Motoyoshy, Y Tanaka, T Nagaoka, M Seno and I Kojima. (2008). Reversal of streptozotocin-induced hyperglycemia by continuous supply of betacellulin in mice. Growth Factors 26:173-179.
36. Moriscot C, F Fraipont, MJ Richard, M Marchand, P Sa-vatier, D Bosco, M Fravot and PY Benhamou. (2005). Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas de-velopmental pathway upon genetic and/or microenviron-mental manipulation in vitro. Stem Cells 23:594-604.
37. Gershengorn MC, AA Hardikar, C Wei, E Geras-Raaka, B Marcus-Samuels and BM Raaka. (2004). Epithelial-to-mes-enchymal transition generates proliferative human islet precursor cells. Science 306:2261-2264.
38. Russ HA, P Ravassard, J Kerr-Conte, F Pattou and S Efrat. (2009). Ephitelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells. Plos One 4:e6417.
39. Atouf F, CH Park, K Pechhold, M Ta, Y Choi and NL Lu-melsky. (2007). No evidence for mouse pancreatic B-cell epithelial to mesenchymal transition in vitro. Diabetes 56: 699-702.
40. Sugiyama K, H Yonemura and H Okamoto. (1991). Effects of poly (ADP-ribose) synthetase inhibitor on B-cells of a canine pancreas alter massive pancreatectomy. Int J Pancreatol 8:85-95.
41. Otonkoski T, GM Beattie, MI Mally, C Ricordi and A Hayek. (1993). Nicotinamide is a potent inducer of endocrine dif-ferentiation in cultured human fetal pancreatic cells. J Clin Invest 92:1459-1466.
42. Rudnick A, TY Ling, H Odagiri, WJ Rutter and MS German. (1994). Pancreatic beta cells express a diverse set of homeo-box genes. Proc Natl Acad Sci USA 91:12203-12207.
43. Harkness JE and JE Wagner. (1995). The Biology and Medicine of Rabbits and Rodents, 4th edn. Williams & Wilkins, Baltimore, MD.
44. Hisanaga E, KI Park, S Yamada, H Hashimoto, T Takeuchi, M Mori, M Seno, K Umezawa, I Takei and I Kojima. (2008). A simple method to induce differentiation of murine bone marrow mesenchymal stem cells to insulin-producing Con-ophylline and betacellulin-delta4. Endrocr J 55:535-543.
45. Johansson A, J Lau, M Sandberg, LA Borg, PU Magnusson and PO Carlsson. (2009). Endothelial cell signaling supports pancreatic beta cell function in the rat. Diabetologia 52:2385-2394.
46. Chu KY, T Lau, PO Carlsson and PS Leung. (2006). Angio-tensin II type 1 receptor blockade improves beta-cell func-tion and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55:367-374.
47. Lau T, PO Carlsson and PS Leung. (2004). Evidence for local angiotensin-generating system and dose-dependent inhibi-tion of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47:240-248.
48. Kobayashi N, T Yuasa and T Okitsu. (2009). Regenerative medicine for diabetes mellitus. Cell Transplant 18:491-496.